losartan has been researched along with hydroxyproline in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (19.05) | 18.2507 |
| 2000's | 10 (47.62) | 29.6817 |
| 2010's | 7 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abassi, ZA; Cuda, G; Golomb, E; Keiser, HR; Panchal, VR; Stylianou, M; Trachewsky, D | 1 |
| Ganjam, VK; Ramires, FJ; Sun, Y; Weber, KT; Zhou, G | 1 |
| Dixon, IM; Jassal, DS; Ju, H; Zhao, S | 1 |
| Busatto, VC; de Moraes, AC; Gomes, Mda G; Milanez, Mda C; Mill, JG | 1 |
| Dixon, IM; Hao, J; Reid, NL; Roth, JC | 1 |
| Matsubara, BB; Matsubara, LS; Paiva, SA; Spadaro, J; Zornoff, LA | 1 |
| Appenroth, D; Beutinger, R; Fleck, C; Lupp, A | 1 |
| Aragon, FF; Cicogna, AC; Cordaro, FR; Gonçalves, G; Okoshi, K; Okoshi, MP; Padovani, CR; Ribeiro, HB; Zornoff, LA | 1 |
| Lu, Y; Yao, HW; Zhao, MH; Zhu, JP | 1 |
| Ahn, SC; Baik, SK; Cho, MY; Choi, YH; Kim, CH; Kim, JW; Kim, MY; Kwon, SO; Park, DH; Rhim, DW | 1 |
| Accatino, L; Aguayo, G; Arrese, M; Duarte, I; Ibañez, P; Miquel, JF; Pizarro, M; Solis, N | 1 |
| Abdallah, HM; El-Batran, SA; El-Demerdash, E; Salam, OM; Shaffie, NM | 1 |
| Anéas, I; Carmo, EC; Frimm, C; Hashimoto, NY; Krieger, JE; Negrão, CE; Oliveira, EM; Rocha, FL; Roque, FR; Rossoni, LV | 1 |
| Chen, N; Li, JJ; Xue, XD | 1 |
| Ceci, L; Cheng, SH; Clayton, NP; Dinardo, CJ; Girgenrath, S; Hunter, RB; Keefe, KA; Leonard, JP; McCullough, JA; McVie-Wylie, A; Nelson, CA; Quigley, LA; Weber, WD; Wentworth, BM | 1 |
| Al-Ismaeel, H; Al-Rikabi, AC; Al-Shabanah, OA; Mansour, MA | 1 |
| Ain-Shoka, A; Badawy, A; Ebeid, F; El-Lakkany, NM; El-Maadawy, W; Hammam, O | 1 |
| Guo, F; Hu, XT; Li, J; Li, S; Liu, ZF; Su, L; Sun, YB | 1 |
| Deng, XL; Ma, XZ; Wang, HF; Wang, LP; Zhao, LM; Zhou, DX | 1 |
| Fang, J; Li, Q; Lu, X; Qiu, M; Sun, S; Wang, W; Wang, Y; Zhang, Y | 1 |
| Chen, P; Liu, X; Qiao, D | 1 |
21 other study(ies) available for losartan and hydroxyproline
| Article | Year |
|---|---|
Angiotensin II maintains, but does not mediate, isoproterenol-induced cardiac hypertrophy in rats.
Topics: Actins; Angiotensin II; Animals; Base Sequence; Biphenyl Compounds; Blood Pressure; Captopril; Cardiomegaly; DNA; DNA Primers; Dose-Response Relationship, Drug; Gene Expression; Genes, fos; Heart; Hydralazine; Hydroxyproline; Imidazoles; Isoproterenol; Labetalol; Losartan; Male; Methyldopa; Molecular Sequence Data; Myocardium; Myosins; Polymerase Chain Reaction; Rats; Rats, Sprague-Dawley; RNA; RNA, Messenger; Tetrazoles; Transcription, Genetic | 1994 |
Fibrous tissue and angiotensin II.
Topics: Actins; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Collagen; Connective Tissue; Croton Oil; Fibroblasts; Granuloma; Hydroxyproline; Imidazoles; Lisinopril; Losartan; Macrophages; Male; Peptidyl-Dipeptidase A; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Wound Healing | 1997 |
Effect of AT1 receptor blockade on cardiac collagen remodeling after myocardial infarction.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biomarkers; Blotting, Northern; Collagen; Hydrogen-Ion Concentration; Hydroxyproline; Immunohistochemistry; Losartan; Male; Myocardial Infarction; Myocardium; Rats; Rats, Sprague-Dawley; RNA, Messenger; Ventricular Function, Left | 1997 |
[Activation of the cardiac angiotensin-converting enzyme after myocardial infarction and its role in ventricular remodeling].
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Captopril; Heart; Heart Ventricles; Hemodynamics; Hydroxyproline; Losartan; Male; Myocardial Infarction; Peptidyl-Dipeptidase A; Proteins; Rats; Rats, Inbred Strains; Rats, Wistar; Vasoconstrictor Agents | 1997 |
Effect of chronic AT(1) receptor blockade on cardiac Smad overexpression in hereditary cardiomyopathic hamsters.
Topics: Analysis of Variance; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Blotting, Northern; Blotting, Western; Cardiomyopathy, Dilated; Collagen; Cricetinae; DNA-Binding Proteins; Female; Fluorescent Antibody Technique; Hydroxyproline; Losartan; Male; Matrix Metalloproteinases; Mesocricetus; Myocardium; RNA, Messenger; Signal Transduction; Smad2 Protein; Trans-Activators; Transforming Growth Factor beta | 2000 |
Effects of losartan on ventricular remodeling in experimental infarction in rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Case-Control Studies; Hydroxyproline; Losartan; Male; Myocardial Infarction; Rats; Rats, Wistar; Survival Analysis; Treatment Outcome; Ventricular Remodeling | 2000 |
Effects of a therapy with losartan and quinaprilat on the progression of chronic renal failure in rats after a single dose of uranyl nitrate or 5/6 nephrectomy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Disease Models, Animal; Disease Progression; Female; Hydroxyproline; Injections, Intraperitoneal; Kidney Failure, Chronic; Losartan; Nephrectomy; p-Aminohippuric Acid; Proteinuria; Rats; Rats, Wistar; Tetrahydroisoquinolines; Uranyl Nitrate | 2003 |
[Blockade of renin-angiotensin system attenuates cardiac remodeling in rats undergoing aortic stenosis].
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Aortic Valve Stenosis; Echocardiography; Hydroxyproline; Hypertrophy, Left Ventricular; Lisinopril; Losartan; Male; Rats; Rats, Wistar; Ventricular Remodeling | 2005 |
Losartan attenuates bleomycin-induced pulmonary fibrosis in rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antibiotics, Antineoplastic; Bleomycin; Body Weight; Glucocorticoids; Hydroxyproline; Losartan; Lung; Male; Malondialdehyde; Prednisone; Pulmonary Fibrosis; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Transforming Growth Factor beta; Transforming Growth Factor beta1; Weight Gain | 2006 |
[Inhibitory effect of angiotensin blockade on hepatic fibrosis in common bile duct-ligated rats].
Topics: Actins; Angiotensin II Type 1 Receptor Blockers; Animals; Bile Ducts; Captopril; Fibrosis; Hydroxyproline; Ligation; Liver; Liver Cirrhosis, Experimental; Losartan; Male; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta | 2007 |
Effect of losartan on early liver fibrosis development in a rat model of nonalcoholic steatohepatitis.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Choline Deficiency; Disease Models, Animal; Fatty Liver; Hydroxyproline; Liver Cirrhosis; Liver Function Tests; Losartan; Male; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction | 2007 |
Inhibition of the renin-angiotensin system attenuates the development of liver fibrosis and oxidative stress in rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; Carbon Tetrachloride; Disease Models, Animal; Dose-Response Relationship, Drug; Fosinopril; Glutathione; Hydroxyproline; Lipid Peroxidation; Lisinopril; Liver; Liver Cirrhosis; Liver Function Tests; Losartan; Male; Oxidative Stress; Rats; Renin-Angiotensin System | 2008 |
Anabolic steroids induce cardiac renin-angiotensin system and impair the beneficial effects of aerobic training in rats.
Topics: Anabolic Agents; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Cardiomegaly; Collagen; Gene Expression Regulation; Heart Rate; Hydroxyproline; Losartan; Male; Myocardial Contraction; Myocardium; Nandrolone; Nandrolone Decanoate; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Swimming; Testosterone; Time Factors; Ventricular Function, Left; Ventricular Remodeling | 2007 |
[Effect of losartan on lung fibrosis in neonatal rats with hyperoxia-induced chronic lung disease].
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Animals, Newborn; Bronchopulmonary Dysplasia; Humans; Hydroxyproline; Hyperoxia; Infant, Newborn; Losartan; Lung; Malondialdehyde; Pulmonary Fibrosis; Rats; Rats, Wistar; Superoxide Dismutase | 2007 |
Inhibiting TGF-β activity improves respiratory function in mdx mice.
Topics: Animals; Biomarkers; Body Weight; Cell Adhesion Molecules; Creatine Kinase; Diaphragm; Dose-Response Relationship, Drug; Enalapril; Gene Expression Regulation; Hand Strength; Hydroxyproline; Inflammation; Losartan; Mice; Mice, Inbred mdx; Muscle Fibers, Skeletal; Myogenin; Organ Size; Respiration; Respiratory Function Tests; RNA, Messenger; Transforming Growth Factor beta | 2011 |
Comparison of angiotensin converting enzyme inhibitors and angiotensin II type 1 receptor blockade for the prevention of premalignant changes in the liver.
Topics: alpha-Fetoproteins; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Anticarcinogenic Agents; Captopril; Carcinoembryonic Antigen; Endostatins; Enzyme-Linked Immunosorbent Assay; Fibroblast Growth Factors; Hydroxyproline; Liver; Liver Neoplasms, Experimental; Losartan; Male; Matrix Metalloproteinase 2; Metallothionein; Perindopril; Precancerous Conditions; Rats; Transforming Growth Factor beta1; Vascular Endothelial Growth Factor A | 2011 |
Potential antifibrotic effects of AT1 receptor antagonist, losartan, and/or praziquantel on acute and chronic experimental liver fibrosis induced by Schistosoma mansoni.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Anthelmintics; Disease Models, Animal; Drug Therapy, Combination; Glutathione; Granuloma; Humans; Hydroxyproline; Liver Cirrhosis, Experimental; Liver Function Tests; Losartan; Male; Matrix Metalloproteinase 2; Mice; Mice, Inbred ICR; Parasite Egg Count; Praziquantel; Schistosomiasis mansoni; Transforming Growth Factor beta1 | 2011 |
Losartan attenuates paraquat-induced pulmonary fibrosis in rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Blotting, Western; Collagen; Herbicides; Hydroxyproline; Losartan; Male; Matrix Metalloproteinase 9; Paraquat; Pulmonary Fibrosis; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Tissue Inhibitor of Metalloproteinase-1; Transforming Growth Factor beta1 | 2015 |
The role of KCa3.1 channels in cardiac fibrosis induced by pressure overload in rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensinogen; Animals; Aorta, Abdominal; Blood Pressure; Cardiomegaly; Cytokines; Fibrosis; Hydroxyproline; Losartan; Male; Myocardium; Potassium Channel Blockers; Pyrazoles; Rats; Rats, Sprague-Dawley; Renin; Shaw Potassium Channels | 2015 |
Metabolomics study of renal fibrosis and intervention effects of total aglycone extracts of Scutellaria baicalensis in unilateral ureteral obstruction rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Biomarkers; Blood Urea Nitrogen; Creatinine; Discriminant Analysis; Disease Models, Animal; Dose-Response Relationship, Drug; Fibrosis; Gas Chromatography-Mass Spectrometry; Hydroxyproline; Kidney; Kidney Diseases; Losartan; Male; Metabolomics; Multivariate Analysis; Phytotherapy; Plant Extracts; Plants, Medicinal; Principal Component Analysis; Rats, Wistar; Scutellaria baicalensis; Time Factors; Ureteral Obstruction; Urological Agents | 2016 |
Effects and Mechanism of SO2 Inhalation on Rat Myocardial Collagen Fibers.
Topics: Angiotensin II; Animals; Blood Pressure; Body Weights and Measures; Collagen; Heart; Heart Ventricles; Hydroxyproline; Hypertension; Losartan; Male; Myocardium; Myocytes, Cardiac; Rats; Sulfur Dioxide; Ventricular Remodeling | 2018 |